Coreline Soft
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Coreline Soft makes AI-powered software that automatically analyses CT scan images to help doctors detect conditions such as lung cancer, chronic obstructive pulmonary disease, and coronary artery calcification, reducing the manual measurement work specialists would otherwise perform by hand.
Its products are used by hospitals and medical institutions, with a growing presence across North America, Europe, and Asia in addition to its home market. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company distributes through both direct sales and a network of domestic and international partners, as well as global medical-device sales platforms.
Summary is AI-generated and may contain errors · figures from DART filings
Coreline Soft has established European subsidiaries and secured lung-cancer screening contracts in Germany, Italy, and a six-country European consortium, giving it a direct international commercial footprint.
Coreline Soft in five facts
What does Coreline Soft do?
Coreline Soft makes AI-powered software that automatically analyses CT scan images to help doctors detect conditions such as lung cancer, chronic obstructive pulmonary disease, and coronary artery calcification, reducing the manual measurement work specialists would otherwise perform by hand.
Where is Coreline Soft listed and in which sector?
Coreline Soft (Korean name: 코어라인소프트) trades under KRX code 384470 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Information Technology sector, Software.
How large is Coreline Soft?
Its market capitalisation was US$31.9M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Coreline Soft's latest annual revenue and operating profit?
For fiscal year 2025, Coreline Soft reported revenue of US$3.2M, an operating loss of US$10.1M and a net loss of US$10.9M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 9.0% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Investor relations (IR) meetingOct 13
- DisclosureOct 13
- Report on large shareholdings (5% rule) (standard)Sep 23
- Report on securities held by executives/major shareholdersSep 23
- [Amended] Grant of stock optionsSep 23
- [Amended] Grant of stock optionsSep 23
- Early redemption of convertible bonds (incl. overseas CBs)
Coreline Soft fully redeemed the remaining US$235K face value of its Series 2 convertible bonds before maturity on July 6, 2026 for US$258K (principal and interest), following the bondholder's exercise of an early-redemption (put) option, leaving the series fully retired.
Capital raise · Jul 6 - Early redemption of convertible bonds (incl. overseas CBs)Capital raise · Apr 6
- Operating results (consolidated) (preliminary) (fair disclosure)
Coreline Soft filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$917K (+45.62% year on year), an operating loss of US$2.04M and a net loss of US$2.26M.
Earnings · Feb 20 - Material event report (convertible bonds)
Coreline Soft disclosed convertible bonds to raise US$8.66M, about 29.6% of its market value.
Capital raise · Feb 12
